Table 2.
Proportion of women (12–20 years during respective year) with diagnoses related to abnormal cervical cell growth
| Any diagnosed with well- woman exam in 2008, n (%) | Diagnosed with Pap tests during 2008, n (%) | Any diagnosed with well- woman exam in 2009, n (%) | Diagnosed with Pap tests during 2009, n (%) | Any diagnosed with well- woman exam in 2010, n (%) | Diagnosed with Pap tests during 2010, n (%) | |
|---|---|---|---|---|---|---|
|
|
||||||
| High risk HPV DNA | 1,584 (2.0) | 1,509 (2.0) | 1,181 (1.8) | |||
| Abnormal cervical cells | 10,701 (13.4) | 10,157 (16.4) | 9,704 (12.6) | 9,257 (16.0) | 7,038 (10.8) | 6,689 (16.7) |
| Atypical glandular cells, endocervicals, endometrials (Excludes CIN, SIL, CIS, CA) | 2,499 (3.1) | 2,347 (3.8) | 1,939 (2.5) | 1,825 (3.2) | 1,368 (2.1) | 1,288 (3.2) |
| Cervical Dysplasia | 1,167 (1.5) | 1,100 (1.8) | 823 (1.1) | 777 (1.3) | 540 (0.8) | 504 (1.3) |
| ASC-US | 5,339 (6.7) | 5,177 (8.4) | 4,832 (6.3) | 4,687 (8.1) | 3,590 (5.5) | 3,475 (8.7) |
| ASC-H | 661 (0.8) | 625 (1.0) | 573 (0.8) | 539 (0.9) | 374 (0.6) | 351 (0.9) |
| LSIL | 4,347 (5.4) | 4,141 (6.7) | 4,031 (5.2) | 3,880 (6.7) | 2,879 (4.4) | 2,751 (6.9) |
| HSIL | 373 (0.5) | 354 (0.6) | 281 (0.4) | 264 (0.5) | 181 (0.3) | 169 (0.4) |
| CIN I | 2,432 (3.0) | 2,313 (3.7) | 1,898 (2.5) | 1,806 (3.1) | 1,270 (2.0) | 1,202 (3.0) |
| CIN II | 633 (0.8) | 608 (1.0) | 452 (0.6) | 425 (0.7) | 240 (0.4) | 229 (0.6) |
| CIN III | 207 (0.3) | 198 (0.3) | 158 (0.2) | 144 (0.3) | 81 (0.1) | 79 (0.2) |
| Malignant neoplasm of cervix | 1 | 1 | 0 | 0 | 0 | 0 |